HeartSciences Inc. (HSCS)
Company Description
HeartSciences Inc., a medical technology company, focuses on applying AI-based technology to an ECG to expand and improve clinical usefulness.
It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction caused by heart disease and/or age-related cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insights, a cloud-based platform to host AI-ECG algorithms on an ECG hardware agnostic basis.
The company was formerly known as Heart Test Laboratories, Inc. and changed its name to HeartSciences Inc. in October 2024.
HeartSciences Inc. was incorporated in 2007 and is headquartered in Southlake, Texas.

Country | United States |
IPO Date | Jun 16, 2022 |
Industry | Medical - Devices |
Sector | Healthcare |
Employees | 15 |
CEO | Andrew Christopher Simpson |
Contact Details
Address: 550 Reserve Street Southlake, Texas United States | |
Website | https://heartsciences.com |
Stock Details
Ticker Symbol | HSCS |
Exchange | NASDAQ |
Fiscal Year | May - April |
Reporting Currency | USD |
CIK Code | 0001468492 |
CUSIP Number | 42254E104 |
ISIN Number | US42254E3027 |
Employer ID | 26-1344466 |
SIC Code | 3842 |
Key Executives
Name | Position |
---|---|
Andrew Simpson | Chief Executive Officer, President & Chairman of the Board of Directors |
Danielle Watson | Chief Financial Officer & Treasurer |
Mark T. Hilz | Chief Operating Officer, Secretary & Director |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Aug 22, 2025 | 8-K | Current Report |
Aug 04, 2025 | 424B5 | Filing |
Aug 04, 2025 | 8-K | Current Report |
Jul 30, 2025 | 4 | Filing |
Jul 30, 2025 | 8-K | Current Report |
Jul 24, 2025 | 8-K | Current Report |
Jul 24, 2025 | 10-K | Annual Report |
Jul 21, 2025 | 8-K | Current Report |
Jul 14, 2025 | 4 | Filing |
Jul 14, 2025 | 8-K | Current Report |